<DOC>
	<DOCNO>NCT01569425</DOCNO>
	<brief_summary>In obese woman polycystic ovary syndrome ( PCOS ) , weight loss improve insulin resistance hyperandrogenism , result improvement clinical symptom . Weight loss require lean PCOS patient ; nevertheless , influence meal time composition glucose metabolism hyperandrogenism may clinical value . In study investigator investigate effect two isocaloric diet different meal time distribution insulin resistance hyperandrogenism lean PCOS patient .</brief_summary>
	<brief_title>Meal Timing Glucose Metabolism Hyperandrogenism Lean Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Insulin resistance hyperinsulinemia play pivotal role pathogenesis polycystic ovary syndrome ( PCOS ) . Hyperinsulinemia stimulate ovarian cytochrome P450c17 alpha activity , obese nonobese woman PCOS , thereby increase serum level 17-alpha-hydroxyprogesterone , androgens concentration , decrease SHBG promote clinical feature hyperandrogenism . In woman PCOS , weight loss improves insulin resistance hyperandrogenism , result improvement clinical symptom . Since lean woman PCOS option weight loss , important know weather diet composition meal time distribution may influence glucose metabolism hyperandrogenism . We hypothesize time pattern increase nutrient intake protein carbohydrates morning , decrease caloric intake night would improve insulin sensitivity hyperandrogenism lean woman PCOS . Objective : The objective study investigate effect two isocaloric diet different meal time distribution insulin resistance hyperandrogenism lean PCOS woman .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<criteria>1 . Subjects ≥18 ≤45 year age 2 . Lean woman PCOS ( BMI : ≤ 25 kg/m2 ) 3 . Signed informed consent 4 . Exclusion lateonset adrenal hyperplasia fast serum 17 hydroxy progesterone concentration 200 ng/dl . 5 . Acceptable health base interview , medical history , physical examination , laboratory test ( SMA20 CBC ) . 6 . Not diet change body weight &gt; 10 lb = 4.5 kg within last 6 month 7 . Stable physical activity pattern three month immediately precede study initiation 8 . Hyperandrogenemia ( elevate free testosterone ) . 9 . Normal liver kidney function 10 . Fasting blood glucose &lt; 110 mg/dl . 11 . No metabolic disease 12 . Usually wake 05:00 07:00 go sleep 22:00 24:00 . 13 . Normal TSH FT4 level serum prolactin 14 . Acceptable health base interview , medical history , physical examination , laboratory test 1 . Diabetes mellitus diagnose fast glucose 2hour OGTT , fast glucose &gt; 110 mg/dl 2 . Clinically significant pulmonary , cardiac , renal , hepatic , neurologic , psychiatric , infectious , malignant disease ( skin cancer ) . 3 . Current use oral contraceptive 4 . Serum creatinine level &gt; 1.5 mg/dl 5 . Abnormal liver function test define increase factor least 2 upper normal limit alanine aminotransferase and/or aspartate 6 . Any physiologic mechanical problem prevent dietary adherence 7 . Pregnant lactate 8 . Participating another dietary program use weightloss medication 9 . Documented suspected history ( within one year ) illicit drug abuse alcoholism . 10 . Use psychotropic anoretic medication month immediately prior study onset 11 . Night rotate shift work 12 . Jet lag 2 week period immediately prior study onset</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>PCOS</keyword>
</DOC>